Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
about
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations.Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.Dosing nomograms: silos on a slope.Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.Prevention of sinonasal inflammation by a synthetic glycosaminoglycan.A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents.
P2860
Q33373700-FAF7EF57-8A4A-4B08-8434-77DE73B72541Q33374658-73F417A1-E7AB-4C25-A0C4-D13422B1BF6EQ33380931-B62FB8BE-E922-41B8-B517-F2A0CE79F717Q33393015-0E1E6B63-1A0C-4D6C-A132-A9CDBEAC199BQ33394050-DD813765-71D7-43EA-B3A0-2B79A19C4496Q33394199-0B439EE6-8AAA-43B1-8FD1-0BD6A01A0617Q33394988-E07D6690-572B-466E-BA02-E13601A62620Q33397244-40C188DF-EBC7-4DB0-A90C-9BF863308E61Q33399307-90D90EA1-F2F3-4F6D-9C58-79F0405FEE7DQ33399580-EFC11784-D78A-4A17-B872-0262FDAFE841Q33400101-52CE53ED-B4FA-4ED1-A2AF-380ED13214DDQ33414886-D50729F0-80EA-4497-AA8D-88F32260919AQ33419374-FBC7BF87-2985-4EE4-85CA-006C9E633019Q33440296-6C1F5F47-C09B-4056-AA03-1527B088E088Q33442600-14879212-F4B8-4E75-AD97-60CDE3ECA01DQ37363635-A89A7FA1-FDF6-426F-85C9-59FAE8953240Q38463548-819A571F-6C30-4DE3-AFF2-54E641394267Q49774684-B005A5B3-20F9-4671-9B43-FBEA9D02A688Q50034024-6D21CBDC-1A3A-43F9-B3CB-07D35E026AAF
P2860
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@ast
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@en
type
label
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@ast
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@en
prefLabel
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@ast
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@en
P2860
P356
P1433
P1476
Evaluation of treatment with d ...... arin-induced thrombocytopenia.
@en
P2093
Jean M Nappi
Valerie L Durkalski
P2860
P304
P356
10.1592/PHCO.26.4.461
P407
P577
2006-04-01T00:00:00Z